REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,126,997 | -1.8% | 109,131 | -12.4% | 0.03% | -12.5% |
| Q1 2023 | $11,326,814 | +105.0% | 124,580 | -14.3% | 0.03% | +88.2% |
| Q4 2022 | $5,525,418 | +357.0% | 145,444 | +202.3% | 0.02% | +325.0% |
| Q3 2022 | $1,209,000 | -55.1% | 48,115 | -52.8% | 0.00% | -33.3% |
| Q4 2021 | $2,690,000 | -63.9% | 102,002 | +97.4% | 0.01% | -90.2% |
| Q1 2020 | $7,460,000 | +261.4% | 51,682 | +114.0% | 0.06% | +771.4% |
| Q1 2019 | $2,064,000 | – | 24,147 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $110,053,269 | 27.64% |
| Ghost Tree Capital, LLC | 500,000 | $18,995,000 | 8.11% |
| First Light Asset Management, LLC | 2,062,453 | $78,352,589 | 7.27% |
| Boxer Capital, LLC | 1,230,004 | $46,727,852 | 2.46% |
| Sofinnova Investments, Inc. | 992,029 | $37,687,182 | 2.24% |
| Tri Locum Partners LP | 141,466 | $5,374,000 | 2.17% |
| MPM BioImpact LLC | 194,181 | $7,376,936 | 1.91% |
| Ikarian Capital, LLC | 201,200 | $7,643,588 | 1.84% |
| KRS Capital Management, LLC | 28,141 | $1,069,077 | 1.46% |
| EMERALD ADVISERS, LLC | 679,772 | $25,824,538 | 1.25% |